Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

SPRO

Spero Therapeutics (SPRO)

Spero Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:SPRO
FechaHoraFuenteTítuloSímboloCompañía
27/03/202516:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SPROSpero Therapeutics Inc
27/03/202515:30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:SPROSpero Therapeutics Inc
27/03/202515:01GlobeNewswire Inc.Spero Therapeutics Announces Fourth Quarter and Full Year 2024 Operating Results and Provides a Business UpdateNASDAQ:SPROSpero Therapeutics Inc
18/03/202507:00GlobeNewswire Inc.Spero Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on Thursday, March 27, 2025NASDAQ:SPROSpero Therapeutics Inc
25/02/202509:15GlobeNewswire Inc.UPDATE – Spero Therapeutics to Present at TD Cowen 45th Annual Health Care ConferenceNASDAQ:SPROSpero Therapeutics Inc
25/02/202506:00GlobeNewswire Inc.Spero Therapeutics to Present at TD Cowen 45th Annual Health Care ConferenceNASDAQ:SPROSpero Therapeutics Inc
05/02/202520:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SPROSpero Therapeutics Inc
10/01/202506:00GlobeNewswire Inc.Spero Therapeutics Provides Business Update and Announces Interim Leadership ChangesNASDAQ:SPROSpero Therapeutics Inc
14/11/202415:05GlobeNewswire Inc.Spero Therapeutics Announces Third Quarter 2024 Operating Results and Provides a Business UpdateNASDAQ:SPROSpero Therapeutics Inc
07/11/202415:05GlobeNewswire Inc.Spero Therapeutics to Report Third Quarter 2024 Financial Results and Provide Business Update on Thursday, November 14, 2024NASDAQ:SPROSpero Therapeutics Inc
29/10/202415:05GlobeNewswire Inc.Spero Therapeutics Announces SPR720 Phase 2a Interim Results and Provides a Business UpdateNASDAQ:SPROSpero Therapeutics Inc
16/10/202415:05GlobeNewswire Inc.Spero Therapeutics Announces Presentation of SPR719 (Active Moiety of SPR720) In Vitro Data Demonstrating Low Propensity for the Development of Resistance at IDWeek 2024NASDAQ:SPROSpero Therapeutics Inc
02/10/202415:30GlobeNewswire Inc.Spero Therapeutics Announces Publication of SPR720 Phase 1 Lung Exposure Data in Antimicrobial Agents and ChemotherapyNASDAQ:SPROSpero Therapeutics Inc
04/09/202415:05GlobeNewswire Inc.Spero Therapeutics to Present at Upcoming September Investor ConferencesNASDAQ:SPROSpero Therapeutics Inc
05/08/202415:25Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SPROSpero Therapeutics Inc
05/08/202415:18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SPROSpero Therapeutics Inc
05/08/202415:01GlobeNewswire Inc.Spero Therapeutics Announces Second Quarter 2024 Operating Results and Provides a Business UpdateNASDAQ:SPROSpero Therapeutics Inc
29/07/202415:05GlobeNewswire Inc.Spero Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update on Monday, August 5, 2024NASDAQ:SPROSpero Therapeutics Inc
03/07/202412:05GlobeNewswire Inc.Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:SPROSpero Therapeutics Inc
15/05/202406:50IH Market NewsU.S. Index Futures Flat Ahead of April CPI Data Release, Oil Prices DropNASDAQ:SPROSpero Therapeutics Inc
06/03/202407:05GlobeNewswire Inc.Spero Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 13, 2024NASDAQ:SPROSpero Therapeutics Inc
28/02/202407:05GlobeNewswire Inc.Spero Therapeutics Announces Clearance of IND for SPR206 to Treat MDR Gram-negative Bacterial InfectionsNASDAQ:SPROSpero Therapeutics Inc
26/02/202407:05GlobeNewswire Inc.Spero Therapeutics to Present at Cowen’s 44th Annual Healthcare ConferenceNASDAQ:SPROSpero Therapeutics Inc
05/02/202415:50Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SPROSpero Therapeutics Inc
31/01/202415:05GlobeNewswire Inc.Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:SPROSpero Therapeutics Inc
05/01/202407:05GlobeNewswire Inc.Spero Therapeutics Provides Corporate Update and 2024 OutlookNASDAQ:SPROSpero Therapeutics Inc
02/01/202407:05GlobeNewswire Inc.Spero Therapeutics Announces First Patient, First Visit for Phase 3 PIVOT-PO Trial Evaluating Tebipenem HBr in Complicated Urinary Tract InfectionsNASDAQ:SPROSpero Therapeutics Inc
15/11/202315:15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SPROSpero Therapeutics Inc
13/11/202315:05GlobeNewswire Inc.Spero Therapeutics Announces Third Quarter 2023 Operating Results and Provides a Business UpdateNASDAQ:SPROSpero Therapeutics Inc
13/11/202305:45IH Market NewsMonday’s Wall Street Highlights: Boeing, Novo Nordisk, Moody’s, StoneCo, and moreNASDAQ:SPROSpero Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SPRO

Su Consulta Reciente

Delayed Upgrade Clock